Subclinical demyelinating lesions may occur in the brains of asymptomatic individuals, and the first-degree relatives of multiple sclerosis (MS) patients are at particular risk. Clinical and MRI examinations were performed in nine sibships from families with two or more cases of MS. These included 14 patients with clinically definite MS, three patients with clinically probable MS, and 27 asymptomatic siblings. Systematic criteria were applied to MRI interpretations to increase their specificity for MS. Thirteen (76%) of the 17 patients with MS showed lesions suggesting MS. Lesions were also found in six (38%) of the 16 asymptomatic siblings under age 50 and in eight (73%) of the 11 over age 50. Judged by stringent criteria, the lesions of only three (11%) of the 27 asymptomatic siblings were considered to be due to demyelination. that subclinical cases may be found in apparently healthy subjects but no detailed analysis of the specificity of the white matter lesions nor familial distribution of the findings were presented. To answer these questions and to increase diagnostic certainty for genetic studies we examined clinically and with MRI the siblings of nine families with two or more cases of MS. Six of the families are from a very high risk area in Finland (the district of Vaasa) where the epidemiology of the disease has been followed up since 1964.20 Subjects and methods Nine sibships from families wimt at least two MS cases were chosen with a total of 48 individuals. All siblings took part in the study; 18 (38%) of them had MS (nine females and nine males). Fifteen patients had clinically definite MS (CDMS) and three had clinically probable MS (CPMS) according to Poser's diagnostic criteria.2' All MS patients had remitting-relapsing disease, and all except one were examined during remission. Their mean age was 50 years (range 33-69 years). The mean duration of the disease was 21 years
Estimates of the familial incidence of multiple sclerosis (MS) vary from 3-6 to 20%. 14 The most sensitive method for showing CNS white matter lesions in MS is MRI. '5 Up to 95% of clinically definite cases, and 50-80% of clinically probable cases show these lesions. '5 18 MRI is therefore today the most reliable technique to study the occurrence of subclinical MS. However, only one study of MRI findings among asymptomatic subjects (other than twins) in MS families has been published. '9 The results support the concept that subclinical cases may be found in apparently healthy subjects but no detailed analysis of the specificity of the white matter lesions nor familial distribution of the findings were presented. To answer these questions and to increase diagnostic certainty for genetic studies we examined clinically and with MRI the siblings of nine families with two or more cases of MS. Six of the families are from a very high risk area in Finland (the district of Vaasa) where the epidemiology of the disease has been followed up since 1964.20 Subjects and methods Nine sibships from families wimt at least two MS cases were chosen with a total of 48 individuals. All siblings took part in the study; 18 (38%) of them had MS (nine females and nine males). Fifteen patients had clinically definite MS (CDMS) and three had clinically probable MS (CPMS) according to Poser's diagnostic criteria.2' All MS patients had remitting-relapsing disease, and all except one were examined during remission. Their mean age was 50 years (range 33-69 years). The mean duration of the disease was 21 years
(1 1-38 years). Of the sibships six (I, II, III, IV, VIII and IX) come from a very high risk area20 (prevalence about 100/100 000) and three (V, VI and VII) are from an area of average risk in Finland (prevalence 50-60/100 000).22 In family I there were seven siblings, one with CDMS and one with CPMS. In family II there were six siblings, one with CDMS and one with CPMS. In family III there were three siblings, two with CDMS, one with CPMS, and the father had had optic neuritis. In family IV there were ten siblings, four with CDMS. In families V and VI there were five siblings, two with CDMS. In families VII and VIII there were two and four siblings, respectively, one of them and the mother had CDMS. In family IX there were six siblings, one of them, an aunt and her son (cousin) had CDMS.
All (IV/8, fig B) , which the 41 asymptomatic subjects over age 50 showed lesions suggesting demyelination but 88% of MS patients had these lesions. In the series ofYetkin et al34 only one of the control group consisting of 100 healthy volunteers, 60 subjects with hypertension and eight patients with dementia showed lesions meeting criteria II. Thus very high specificity for MS can be obtained with these criteria, and they would then be preferred in the scans of elderly subjects. However, the use of such stringent criteria may exclude some cases of MS, and the relaxation of these criteria would inevitably introduce several subjects with vascular disease. Consequently, it seems that the most reliable interpretations can be drawn from the studies of subjects in age group under 50 or even preferably in age group under 40, in which the prevalence of white matter lesions in the general population is extremely low. When studying families multiply affected by MS it is difficult to restrict MRI studies only to sibships under age 40, because of the late diagnosis of MS in many cases. Given the limitation that criteria II may exclude cases of MS the very low frequency of false positives encountered with these criteria justifies their use in order to diminish the most probable bias in these studies: classifying lesions due to vascular disease as demyelinating. Thirteen (76%) of 17 patients with CDMS or CPMS fulfilled both criteria for specificity of the lesions. Hence, the sensitivity was not reduced when criteria II were applied. Family IV represents one of the largest reported aggregation of siblings with CDMS: four out of ten siblings had CDMS. In this family there was one possible subclinical cases of MS, too. As has been shown earlier35 multiple lesions can be found on MRI despite normal clinical findings among MS patients, most probably because up to 75% of lesions identified by MRI can be clinically "silent".36 Even such large and numerous lesions that were found in fig A did not cause any symptoms or signs at the time of examination.
Among clinically asymptomatic siblings under age 50 none had lesions fulfulling criteria II. Two subjects (I/2 and VIII/2) showed lesions fulfilling criteria I, which in this age group suggests demyelination. In the age group over 50 there were two asymptomatic men (IV/6 and V/i, both possessing risk factors for stroke) whose lesions fulfilled criteria I, but not criteria II. These are more likely to be nondemyelinating lesions rather than evidence for subclinical MS. Thus three (11%) out of 27 asymptomatic individuals, two under age 50 fulfilling criteria I and one over age 50 fulfilling criteria II, were candidates for having subclinical MS. All these subjects were from multiplex families from the area of very high risk for MS and therefore the results can not be extrapolated to families with a single MS case. Follow up of these subjects for future symptoms or new lesions by repeated MRI will be of interest. In the series of Lynch et al 9 the lesions of two (9-5%) out of 21 asymptomatic subjects over age 50 in MS families fulfilled criteria II. They may represent subclinical demyelination in the age group over 50, a finding quite similar to ours (1/11, 9%). In the age group under 50 Lynch et al found four asymptomatic subjects out of 24 who had lesions, but none of these seemed to meet the criteria I used in our study. 
